BayWa's Restructuring Strategy Unravels as Key Unit Underperforms

BayWa's €1.7B stake sale plan for its renewable unit fails, extending debt reduction to 2030. CEO departs amid regulatory scrutiny and tightened financial controls.

A critical component of BayWa's debt reduction plan has faltered, pushing the Munich-based agricultural and energy group into a new phase of uncertainty. An ad-hoc announcement released on March 11 revealed that BayWa r.e., the renewable energy subsidiary central to the entire restructuring effort, is falling significantly short of its projected targets.

Revised Financial Projections and Extended Timeline

The original rescue concept, which relied on generating approximately €1.7 billion from the sale of a 51% stake in BayWa r.e. by the end of 2028, is now deemed unachievable. According to a new medium-term plan covering 2026–2028, this figure can no longer be reached. Company management cites deteriorating regulatory and economic conditions for renewable energy project developers as the primary cause, with the United States being a particular area of concern. The US was BayWa r.e.'s most important single market in the 2024 financial year, with 534.7 megawatts of capacity sold. Shifts in US energy policy have substantially reduced achievable sale prices.

The updated financial roadmap now forecasts an adjusted EBITDA of just over €140 million for 2027, rising to around €150 million by the end of 2030. Consequently, the planning horizon has been extended by two years to 2030.

Regarding the overall debt reduction target of €4 billion by 2028, only about 33% has been achieved to date. Since 2025, BayWa has lowered its debt burden by roughly €1.3 billion. A major contributor was the sale of its trading subsidiary, Cefetra, which removed bank liabilities exceeding €600 million from its consolidated financial statements. The remaining €2.7 billion in required reductions presents a growing challenge.

Leadership Overhaul and Tighter Financial Controls

The setbacks have triggered immediate personnel changes. CEO Dr. Frank Hiller will depart on July 31, 2026, with his role as Chairman of the Management Board ending effective immediately. Furthermore, three Supervisory Board members are resigning: Monika Hohlmeier and Michael Höllerer at the end of March, and Monique Surges at the end of May. The departing members had faced internal criticism for supporting the debt-financed expansion strategy.

In parallel, corporate governance controls have been tightened. The Supervisory Board must now approve all transactions exceeding €50 million, a substantial reduction from the previous threshold of €200 million.

Regulatory Scrutiny and Reporting Delays

Compounding the situation is an ongoing investigation by the German financial regulator, BaFin. Since October 2024, BaFin has been examining the 2023 annual financial statements over concerns regarding insufficient disclosure of financing risks. As a result, the publication of the consolidated financial statements for 2025 will likely be delayed until the fourth quarter of 2026.

In the short term, BayWa is negotiating a standstill agreement with its core banks and major shareholders, intended to last until autumn 2026. This agreement is meant to provide the necessary time to reformulate the restructuring concept. The company's fourth-quarter results, due on March 26, are expected to reveal the full extent of impairment requirements for BayWa r.e. and indicate whether the planned sale of the New Zealand-based subsidiary T&G Global—estimated at €300 million—can help stabilize the company's trajectory.